Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,468
Closed -$206K 1028
2022
Q1
$206K Buy
+7,468
New +$265K 0.06% 326
2021
Q4
Sell
-12,032
Closed -$428K 1077
2021
Q3
$428K Sell
12,032
-3,608
-23% -$143K 0.1% 211
2021
Q2
$613K Buy
15,640
+3,219
+26% +$110K 0.14% 146
2021
Q1
$453K Sell
12,421
-10,852
-47% -$451K 0.13% 160
2020
Q4
$997K Buy
+23,273
New +$855K 0.29% 88

Other funds holding XPEV

Exane Derivatives's XPEV Position: Q2 2022 in Review

Exane Derivatives sold out of XPeng (XPEV) in Q2 2022, closing a stake of 7,468 shares — an estimated $206K sold.

Exane Derivatives first reported a position in XPEV in Q4 2020 and held it in 5 quarters. The position peaked at $997K in Q4 2020. 304 funds tracked by Wall St. Rank hold XPEV as of Q2 2022.

  • Exane Derivatives reported no remaining XPeng position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 7,468 XPeng shares in Q2 2022, an estimated $206K.
  • Exane Derivatives first reported a position in XPeng in Q4 2020 and held it in 5 quarters.
  • Exane Derivatives's XPeng position peaked at $997K in Q4 2020.
  • 304 funds tracked by Wall St. Rank held XPeng as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.